Analytics

Еженедельный обзор принятых и готовящихся к рассмотрению и утверждению отраслевых нормативно-правовых актов

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir…

Since the beginning of the year, the Ministry of Health held about 40 biddings under the Seven Diseases program to purchase some 26 bn RUB-worth drugs. Pharmstandard won the biddings to total approximately 11 bn RUB. In early October, it transpired that 70% of Biocad shares would be acquired by Joyful Group, an offshore company…

The first generic of sofosbuvir, a hepatitis C treatment, was registered in Belarus. Gilead that is the originator drug owner, did not patent the drug in that country, and, in accordance with the international law, Belarus has the right to manufacture and register the drug. The drug price in that country turned out to be higher…

As of today, the regulatory environment for the drug circulation within the framework of the Eurasian Economic Union’s common market has been formed. At the same time, in fact, the common market has not been launched into operation yet. The drug interchangeability issue that for quite a while has been putting a brake on this process…

President of the Russian Retail Market Expert Association Andrey Karpov stated that if supermarket owners got seriously interested in selling pharmaceuticals then the pharmacy segment players who had been fighting fiercely against the initiative to legalize OTC drug sales at stores would find themselves amidst food business before…

A compulsory licensing was one of the topics on the agenda of the 7th international conference “What is going on in the pharmaceutical market?”. First this initiative put forward by the Federal Antimonopoly Service (FAS) was thoroughly analyzed by lawyers, patent law experts, and economists. Then the floor was taken by Timofey…